RxCelerate - About the company
RxCelerate is a seed company based in Babraham (United Kingdom), founded in 2012 by Jill Reckless and David Grainger. It operates as a Provider of pre-clinical contract research services. RxCelerate has raised an undisclosed amount in funding, with a current valuation of £*****. The company has 228 active competitors, including 12 funded and 42 that have exited. Its top competitors include companies like Tigermed, Gubra and Yashraj Biotechnology.
Company Details
RxCelerate provides pre-clinical contract research services. The company specializes in taking lead candidates from drug discovery and making them IND-ready. Services offered include GLP efficacy, toxicology and ADME studies.
- Website
- www.rxcelerate.com/
- Social
- Email ID
- *****@rxcelerate.com
- Phone Number
- +44 **********
Key Metrics
Founded Year
2012
Location
Babraham, United Kingdom
Stage
Seed
Latest Funding Round
Post Money Valuation
£***** as on Feb 19, 2024
Investors
Ranked
6th among 228 active competitors
Employee Count
62 as on Aug 31, 2026
Investment & Acquisitions
Legal entities associated with RxCelerate
RxCelerate is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
RXCELERATE LIMITED CIN: 8284658 , United Kingdom, Active | Nov 06, 2012 | - | 97 (As on Nov 30, 2024) |
Sign up to download RxCelerate's company profile
RxCelerate's funding and investors
RxCelerate has raised funding over 1 round. RxCelerate has 1 institutional investor.
Here is the list of recent funding rounds of RxCelerate:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 19, 2024 | 9608858 | Seed | 9141256 | 7742202 | 8283284 | 6299811 |
Access funding benchmarks and valuations. Sign up today!View details of RxCelerate's funding rounds and investors
RxCelerate's founders and board of directors
Founder? Claim ProfileThe founders of RxCelerate are Jill Reckless and David Grainger. Jill Reckless is the CEO of RxCelerate.
Here are the details of RxCelerate's key team members:
- Jill Reckless: Co-Founder & CEO of RxCelerate. Contact Info: 1 email address
- David Grainger: Co-Founder of RxCelerate.
View details of RxCelerate's Founder profiles and Board Members
RxCelerate's employee count trend
RxCelerate has 62 employees as of Aug 26. Here is RxCelerate's employee count trend over the years:
Uncover RxCelerate's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
RxCelerate's Competitors and alternates
Top competitors of RxCelerate include Tigermed, Gubra and Yashraj Biotechnology. Here is the list of Top 10 competitors of RxCelerate, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of drug development and pre clinical services | - | 51/100 | ||
2nd | Preclinical CRO focussed on developing treatments for NAFLD/NASH, diabetes, and obesity | - | - | 49/100 | |
3rd | Yashraj Biotechnology 1999, Mumbai (India), Early Stage | Provider of recombinant antigens and antibodies for diagnostic and research | $492K | 49/100 | |
4th | BioQual 1981, Rockville (United States), Public | Integrated CRO focused on infectious diseases | - | - | 48/100 |
5th | Gentronix 1999, Alderley Edge (United Kingdom), Acquired | Providr of in-vitro and in-vivo genetic toxicology screening services | $3.84M | 47/100 | |
6th | RxCelerate 2012, Babraham (United Kingdom), Seed | Provider of pre-clinical contract research services | - | 41/100 | |
7th |  GV Research Platform 2020, Hyderabad (India), Funding Raised | Provides platform for conducting research and drug development services | - | 41/100 | |
8th | ReveraGen 2008, Rockville (United States), Funding Raised | Developer of steroids for treating Duchenne muscular dystrophy | - | 41/100 | |
9th | Absorption 1996, Exton (United States), Acquired | Premier life science service provider offering comprehensive R&D and manufacturing solutions | - | - | 41/100 |
10th |  Shanghai Semero Biotechnology 2014, Shanghai (China), Series C | Provider of diversified preclinical services for brain-related disorders | $20.8M | 41/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on RxCelerate's competitors? Click here to see the top ones
RxCelerate's Investments and acquisitions
RxCelerate has made 2 investments in companies including Rivus Pharmaceuticals and Rivus Pharmaceuticals. RxCelerate has also acquired 6 companies including Methuselah Health and Prosarix.Here is the list of investments & acquisitions:
Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Nov 22, 2022 | Acquisition | 2015 | Babraham (United Kingdom) | |
Sep 22, 2022 | Investments | 2019 | Charlottesville (United States) | |
Jun 20, 2021 | Investments | 2019 | Charlottesville (United States) |
Want to know more about where corporates are investing? Sign up today!See all acquisitions by RxCelerate
Reports related to RxCelerate
Here is the latest report on RxCelerate's sector:
News related to RxCelerate
Filter this list•
RxCelerate Assembles a World-Class Scientific Advisory Board for its Biologics Discovery UnitRxCelerate•Apr 29, 2025•RxCelerate
•
•
RxCelerate & Babraham Research Campus host panel on “Prioritising mental health in the workplace”RxCelerate•Oct 15, 2024•RxCelerate, Babraham Research Campus
•
PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery diseaseRxCelerate•Sep 18, 2024•RxCelerate, Plaquetec
•
•
New Drosophila screening lab further expands RxCelerate’s drug discovery and development capabilitiesRxCelerate•Apr 24, 2024•RxCelerate
•
RxCelerate Acquires Methuselah Health and Launches ProQuant™ World-Beating Proteomics ServiceNewswire•Nov 22, 2022•RxCelerate, Methuselah Health
•
Weight loss player gets attention of RA Capital, walks away with $132M to keep pursuing big targetsEndPoints News•Sep 22, 2022•Rivus Pharmaceuticals, RA Capital Management, Rivus, Bain Capital Life Sciences and 4 others
•
RxCelerate Launch RxNfinity™: A Next-Generation Machine Learning-Enabled Small Molecule Discovery PlatformGlobeNewswire•Jul 19, 2022•RxCelerate
•
New Cambridge VC fund invests in $35m round for US pioneerBusiness Weekly newspaper•Jul 20, 2021•RxCelerate
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about RxCelerate
Explore our recently published companies
- hb-101.com - Yokkaichi based, 1999 founded, Unfunded company
- United Angels Dream - Phillipsburg based, 2003 founded, Unfunded company
- Jim Davis - Ireland based, 1980 founded, Unfunded company
- Canon - India based, 1977 founded, Unfunded company
- Laura Carrillo - Unfunded company
- Logista Italia - Italy based, 2004 founded, Unfunded company
